Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

265 Odcinki

  1. Clozapine-Induced Myocarditis

    Opublikowany: 8.03.2022
  2. Does Cannabis Use Cause Psychiatric Disorders?

    Opublikowany: 3.03.2022
  3. Treatment Strategies for Treatment-Resistant OCD

    Opublikowany: 26.02.2022
  4. Lithium Augmentation for Psychotic Depression

    Opublikowany: 21.02.2022
  5. Prevention and Treatment Strategies for Agitation and Dementia

    Opublikowany: 16.02.2022
  6. Choosing an Antipsychotic for Psychotic Depression

    Opublikowany: 11.02.2022
  7. Neurological and Psychiatric Sequelae Due to COVID-19

    Opublikowany: 6.02.2022
  8. SNRIs + Antipsychotics for Psychotic Depression

    Opublikowany: 1.02.2022
  9. Approaches for Addressing Tobacco Use Disorder

    Opublikowany: 27.01.2022
  10. ECT the First-Choice Treatment for Psychotic Depression

    Opublikowany: 22.01.2022
  11. Metabolic Characteristics of Newer Second-Generation Antipsychotics

    Opublikowany: 17.01.2022
  12. Prescribing Antipsychotics During Breastfeeding

    Opublikowany: 12.01.2022
  13. Fluvoxamine for Treating COVID-19

    Opublikowany: 7.01.2022
  14. Prescribing Antidepressants During Breastfeeding

    Opublikowany: 2.01.2022
  15. Treatment Strategies for Acute and Chronic Insomnia

    Opublikowany: 28.12.2021
  16. Drug Use in Breastfeeding and Adverse Effects

    Opublikowany: 23.12.2021
  17. Marine Omega-3 Fatty Acid Supplementation for BPD

    Opublikowany: 18.12.2021
  18. Breastfeeding and Estimating Infant Drug Exposure

    Opublikowany: 13.12.2021
  19. A Method for Tapering Antipsychotics

    Opublikowany: 8.12.2021
  20. Management of Psychiatric Comorbidities With Alcohol Use Disorder

    Opublikowany: 3.12.2021

12 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site